342 related articles for article (PubMed ID: 33439272)
21. OP9 bone marrow stroma cells differentiate into megakaryocytes and platelets.
Matsubara Y; Ono Y; Suzuki H; Arai F; Suda T; Murata M; Ikeda Y
PLoS One; 2013; 8(3):e58123. PubMed ID: 23469264
[TBL] [Abstract][Full Text] [Related]
22. Ex vivo production of platelets from stem cells.
Avanzi MP; Mitchell WB
Br J Haematol; 2014 Apr; 165(2):237-47. PubMed ID: 24521452
[TBL] [Abstract][Full Text] [Related]
23. Integrated Biophysical and Biochemical Signals Augment Megakaryopoiesis and Thrombopoiesis in a Three-Dimensional Rotary Culture System.
Yang Y; Liu C; Lei X; Wang H; Su P; Ru Y; Ruan X; Duan E; Feng S; Han M; Xu Y; Shi L; Jiang E; Zhou J
Stem Cells Transl Med; 2016 Feb; 5(2):175-85. PubMed ID: 26702125
[TBL] [Abstract][Full Text] [Related]
24. Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells.
Takayama N; Nishimura S; Nakamura S; Shimizu T; Ohnishi R; Endo H; Yamaguchi T; Otsu M; Nishimura K; Nakanishi M; Sawaguchi A; Nagai R; Takahashi K; Yamanaka S; Nakauchi H; Eto K
J Exp Med; 2010 Dec; 207(13):2817-30. PubMed ID: 21098095
[TBL] [Abstract][Full Text] [Related]
25. [Novel physico-chemical regulation mechanism enables the production of 100 billion platelets].
Nakamura S; Eto K
Rinsho Ketsueki; 2020; 61(6):628-633. PubMed ID: 32624536
[TBL] [Abstract][Full Text] [Related]
26. Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells.
Nakamura S; Takayama N; Hirata S; Seo H; Endo H; Ochi K; Fujita K; Koike T; Harimoto K; Dohda T; Watanabe A; Okita K; Takahashi N; Sawaguchi A; Yamanaka S; Nakauchi H; Nishimura S; Eto K
Cell Stem Cell; 2014 Apr; 14(4):535-48. PubMed ID: 24529595
[TBL] [Abstract][Full Text] [Related]
27. In vitro generation of megakaryocytes and platelets from human embryonic stem cells and induced pluripotent stem cells.
Takayama N; Eto K
Methods Mol Biol; 2012; 788():205-17. PubMed ID: 22130710
[TBL] [Abstract][Full Text] [Related]
28. Development of platelet replacement therapy using human induced pluripotent stem cells.
Nakamura S; Sugimoto N; Eto K
Dev Growth Differ; 2021 Feb; 63(2):178-186. PubMed ID: 33507533
[TBL] [Abstract][Full Text] [Related]
29. Generation of Megakaryocytes and Platelets from Human Pluripotent Stem Cells.
Pick M
Methods Mol Biol; 2016; 1307():371-8. PubMed ID: 24297316
[TBL] [Abstract][Full Text] [Related]
30. Progress in bio-manufacture of platelets for transfusion.
Heazlewood SY; Nilsson SK; Cartledge K; Be CL; Vinson A; Gel M; Haylock DN
Platelets; 2017 Nov; 28(7):649-656. PubMed ID: 28067095
[TBL] [Abstract][Full Text] [Related]
31. Pluripotent stem cells reveal the developmental biology of human megakaryocytes and provide a source of platelets for clinical application.
Takayama N; Eto K
Cell Mol Life Sci; 2012 Oct; 69(20):3419-28. PubMed ID: 22527724
[TBL] [Abstract][Full Text] [Related]
32. Platelet bioreactor: accelerated evolution of design and manufacture.
Thon JN; Dykstra BJ; Beaulieu LM
Platelets; 2017 Jul; 28(5):472-477. PubMed ID: 28112988
[TBL] [Abstract][Full Text] [Related]
33. Developing a co-culture system for effective megakaryo/thrombopoiesis from umbilical cord blood hematopoietic stem/progenitor cells.
Hatami J; Andrade PZ; Alves de Matos AP; Djokovic D; Lilaia C; Ferreira FC; Cabral JM; da Silva CL
Cytotherapy; 2015 Apr; 17(4):428-42. PubMed ID: 25680300
[TBL] [Abstract][Full Text] [Related]
34. Understanding platelet generation from megakaryocytes: implications for in vitro-derived platelets.
Sim X; Poncz M; Gadue P; French DL
Blood; 2016 Mar; 127(10):1227-33. PubMed ID: 26787738
[TBL] [Abstract][Full Text] [Related]
35. Conditional CRISPR-mediated deletion of Lyn kinase enhances differentiation and function of iPSC-derived megakaryocytes.
Moroi AJ; Newman PJ
J Thromb Haemost; 2022 Jan; 20(1):182-195. PubMed ID: 34624170
[TBL] [Abstract][Full Text] [Related]
36. Structurally graduated collagen scaffolds applied to the ex vivo generation of platelets from human pluripotent stem cell-derived megakaryocytes: Enhancing production and purity.
Shepherd JH; Howard D; Waller AK; Foster HR; Mueller A; Moreau T; Evans AL; Arumugam M; Bouët Chalon G; Vriend E; Davidenko N; Ghevaert C; Best SM; Cameron RE
Biomaterials; 2018 Nov; 182():135-144. PubMed ID: 30118981
[TBL] [Abstract][Full Text] [Related]
37. FLI1 level during megakaryopoiesis affects thrombopoiesis and platelet biology.
Vo KK; Jarocha DJ; Lyde RB; Hayes V; Thom CS; Sullivan SK; French DL; Poncz M
Blood; 2017 Jun; 129(26):3486-3494. PubMed ID: 28432223
[TBL] [Abstract][Full Text] [Related]
38. Towards Reduction or Substitution of Cytotoxic DMSO in Biobanking of Functional Bioengineered Megakaryocytes.
Pogozhykh D; Eicke D; Gryshkov O; Wolkers WF; Schulze K; Guzmán CA; Blasczyk R; Figueiredo C
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081128
[TBL] [Abstract][Full Text] [Related]
39. miRNAs can increase the efficiency of ex vivo platelet generation.
Emmrich S; Henke K; Hegermann J; Ochs M; Reinhardt D; Klusmann JH
Ann Hematol; 2012 Nov; 91(11):1673-84. PubMed ID: 22763947
[TBL] [Abstract][Full Text] [Related]
40. Miniaturized 3D bone marrow tissue model to assess response to Thrombopoietin-receptor agonists in patients.
Di Buduo CA; Laurent PA; Zaninetti C; Lordier L; Soprano PM; Ntai A; Barozzi S; La Spada A; Biunno I; Raslova H; Bussel JB; Kaplan DL; Balduini CL; Pecci A; Balduini A
Elife; 2021 Jun; 10():. PubMed ID: 34059198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
